Scholarlink

<p>This study investigated the combined effects of quercetin (Que) and shRNA-mediated XBP1 silencing on the MCF7 and MDA-MB-231 breast cancer cell lines. Que was selected because of its well-known anticancer effects. XBP1, on the other hand, was targeted because it has been reported to play a critical role in the progression of breast cancer and in stress-adaptive signaling. Cell viability and colony formation assays showed that Que and XBP1 silencing reduced cell growth, with the combined treatment producing a more pronounced inhibitory effect. In both cell lines, the combined treatment was associated with increased expression of apoptosis-related markers, including CASP3, CASP8 and CASP9, supporting a pro-apoptotic response. In addition, treatment-related changes were observed in EMT-associated markers, including increased CDH1 expression and decreased CDH2 expression, suggesting modulation of EMT-related molecular characteristics. Overall, these findings indicate that the combined application of XBP1 silencing and Que exerts anti-proliferative and apoptosis-associated effects on breast cancer cells and may also influence EMT-related molecular pathways. These results support the potential of combining RNAi-based approaches with plant-derived natural compounds as a therapeutic strategy for breast cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

XBP1 gene silencing augments quercetin-induced apoptosis and anti-metastatic activity in breast cancer cell lines

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月17日

查看全文
  • Sedef Akçaalan,
  • Canan Eroğlu Güneş,
  • Ercan Kurar

摘要

This study investigated the combined effects of quercetin (Que) and shRNA-mediated XBP1 silencing on the MCF7 and MDA-MB-231 breast cancer cell lines. Que was selected because of its well-known anticancer effects. XBP1, on the other hand, was targeted because it has been reported to play a critical role in the progression of breast cancer and in stress-adaptive signaling. Cell viability and colony formation assays showed that Que and XBP1 silencing reduced cell growth, with the combined treatment producing a more pronounced inhibitory effect. In both cell lines, the combined treatment was associated with increased expression of apoptosis-related markers, including CASP3, CASP8 and CASP9, supporting a pro-apoptotic response. In addition, treatment-related changes were observed in EMT-associated markers, including increased CDH1 expression and decreased CDH2 expression, suggesting modulation of EMT-related molecular characteristics. Overall, these findings indicate that the combined application of XBP1 silencing and Que exerts anti-proliferative and apoptosis-associated effects on breast cancer cells and may also influence EMT-related molecular pathways. These results support the potential of combining RNAi-based approaches with plant-derived natural compounds as a therapeutic strategy for breast cancer.